Gluintol (Glucose Monohydrate)

Gluintol is employed in pharmaceutical manufacturing where glucose monohydrate serves as an inert carrier or functional additive.

• As a filler or diluent in tablets, capsules and oral powders.
• To provide a readily soluble source of carbohydrate in liquid formulations.
• As a sweetening agent that improves palatability of pediatric medicines.
• To aid in the preparation of oral rehydration solutions and electrolyte mixes.
• As a stabilizing excipient that supports the integrity of biologic products.
• In compounding of custom formulations where a neutral carbohydrate base is required.

When taken orally, glucose monohydrate is generally well tolerated, but some individuals may experience mild or, rarely, serious adverse effects.

Common

• Mild gastrointestinal discomfort such as bloating or flatulence.
• Transient increase in thirst or mild dry mouth.
• Slight rise in blood glucose levels that normalizes quickly.
• Nausea or mild stomach upset after ingestion.

Serious

• Allergic reactions including rash, itching or swelling of the face and throat.
• Severe hyperglycemia leading to symptoms such as rapid breathing or confusion.
• Anaphylactic shock, a rare but life‑threatening allergic response.
• Osmotic diuresis causing excessive urination and electrolyte imbalance.

Because glucose monohydrate can affect blood sugar and fluid balance, certain precautions are recommended before using Gluintol.

• Assess blood glucose levels in patients with diabetes or impaired glucose tolerance.
• Use caution in individuals prone to dehydration or with renal insufficiency.
• Avoid excessive dosing in children, as rapid glucose spikes may occur.
• Monitor for signs of allergic reaction, especially in those with known carbohydrate sensitivities.
• Store the product in a cool, dry place to prevent microbial growth.
• Keep out of reach of infants and pets to prevent accidental ingestion.

Glucose monohydrate may interact with certain medications or medical conditions, influencing absorption or metabolic response.

Avoid

• Concurrent use with high‑dose insulin or other potent hypoglycemic agents, which may cause severe hypoglycemia.
• Co‑administration with medications that contain carbohydrate‑based excipients, potentially leading to cumulative glucose load.

Use with caution

• Antidiabetic drugs such as metformin, sulfonylureas, or GLP‑1 agonists, requiring closer glucose monitoring.
• Diuretics that affect electrolyte balance, as glucose can influence fluid shifts.
• Medications that slow gastric emptying, which may alter glucose absorption rates.